Most rare diseases such as Stargardt's presently have no treatments available. So its very exciting that there are a few clinical trials taking place investigating potential treatments.
Last month (October 2014) in The Lancet, Ocata Therapeutics (Formerly Advanced Cell Technology) published their preliminary phase 1 clinical data for their Stem Cell therapy trials for Stargardt's Macular Dystrophy (SMD) and Age Related Macular Degeneration (AMD).
I decided to post about the Ocata preliminary data first. I will discuss the other two trials (Oxford BioMedica and Alkeus Pharmaceuticals) when that information is released.
In the video I discuss the safety findings of the stem cell therapy and the encouraging efficacy data. The links to The Lancet article and other items mentioned are below the video.
Last month (October 2014) in The Lancet, Ocata Therapeutics (Formerly Advanced Cell Technology) published their preliminary phase 1 clinical data for their Stem Cell therapy trials for Stargardt's Macular Dystrophy (SMD) and Age Related Macular Degeneration (AMD).
I decided to post about the Ocata preliminary data first. I will discuss the other two trials (Oxford BioMedica and Alkeus Pharmaceuticals) when that information is released.
In the video I discuss the safety findings of the stem cell therapy and the encouraging efficacy data. The links to The Lancet article and other items mentioned are below the video.
The Lancet Article: http://t.co/tZ9WItoDLg
What are stem cells? Blogpost: http://goo.gl/fb/DbHMHB
Wall Street Journal Video: http://on.wsj.com/1p9Zt91
Stargardt Trial: https://clinicaltrials.gov/ct2/show/N...
AMD Trial: https://clinicaltrials.gov/ct2/show/N...
Previous video: http://goo.gl/fb/frp18n
TED Talk Tuesday: Dr Robert Lanza - Cloning, Stem Cells & Regenerating Life
TED Talk Tuesday: Dr Robert Lanza - Cloning, Stem Cells & Regenerating Life
_______
Connect With Me -
1 comment :
I was diagnosed with Macular Dystrophy in my 20's and am now 35. Is this trial for someone like me?
Post a Comment